|
MUTED expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.19079999697058E-08 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.63025148935958E-12 |
| Stage1-vs-Stage2 |
2.940800E-01 |
| Stage1-vs-Stage3 |
8.673600E-02 |
| Stage1-vs-Stage4 |
8.415700E-03 |
| Stage2-vs-Stage3 |
2.942400E-02 |
| Stage2-vs-Stage4 |
4.524900E-03 |
| Stage3-vs-Stage4 |
3.599600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.12500000004623E-06 |
| Normal-vs-Asian |
3.63129970537557E-10 |
| Caucasian-vs-AfricanAmerican |
5.443200E-01 |
| Caucasian-vs-Asian |
4.847000E-01 |
| AfricanAmerican-vs-Asian |
9.362800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.372000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62680979798324E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.64612767861172E-12 |
| Normal-vs-Age(81-100Yrs) |
6.848800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.009800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.321700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.150600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.052620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.034800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.323800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.476900E-03 |
| Classical-VS-Follicular |
8.604300E-02 |
| Classical-VS-Other |
3.158200E-01 |
| Classical-VS-Normal |
3.87749832242434E-11 |
| Tall-VS-Follicular |
2.108400E-01 |
| Tall-VS-Other |
9.073600E-01 |
| Tall-VS-Normal |
1.66755498298699E-13 |
| Follicular-VS-Other |
7.041000E-01 |
| Follicular-VS-Normal |
1.69697589313955E-12 |
| Other-VS-Normal |
5.037700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.66373598126302E-15 |
| N0-vs-N1 |
3.595100E-03 |
|
|
